Sanofi Sponsored ADR Stock

$50.37

0.48% yesterday

Nasdaq, Jul 25, 10:00 pm CET

ISIN

US80105N1054

Symbol

SNY

Reports

Quarter | Annual

Index

NASDAQ Composite

Sector

Pharmaceuticals, Biotechnology & Life Sciences

Industry

Pharmaceuticals

Overview Dividends Analysts Charts News Strategies

Sanofi Sponsored ADR Stock price

$50.37

-1.82 3.49% 5Y

Nasdaq, Closing price Fri, Jul 25 2025

+0.24 0.48%

ISIN

US80105N1054

Symbol

SNY

Reports

Quarter | Annual

Index

NASDAQ Composite

Sector

Pharmaceuticals, Biotechnology & Life Sciences

Industry

Pharmaceuticals

Key metrics

Basic

Market capitalization

$121.3b

Enterprise Value

$136.6b

Net debt

$15.3b

Cash

$9.4b

Shares outstanding

1.3b

Valuation (TTM | estimate)

P/E

5.1 | 5.1

P/S

1.5 | 2.3

EV/Sales

1.7 | 2.5

EV/FCF

10.6

P/B

1.4

Dividends

DPS

$2.20

Yield 1Y | 5Y

4.4% | 4.0%

Growth 1Y | 5Y

7.8% | 5.3%

Payout 1Y | 3Y

39.3% | 32.5%

Increased

2 Years

Financials (TTM | estimate)

Revenue

$81.1b | $53.8b

EBITDA

$21.9b | $16.9b

EBIT

$18.8b | $14.2b

Net Income

$12.0b | $12.3b

Free Cash Flow

$12.8b

Financial Health

Equity Ratio

58.4%

Return on Equity

7.2%

ROCE

16.1%

ROIC

13.0%

Debt/Equity

0.3

EPS

$9.8

FCF per Share

$10.2

Short interest

0.2%

Employees

83k

Rev per Employee

$630.0k

As a Free StocksGuide user, you can view scores for all 7,027 stocks worldwide.

Get Started for Free Today

Sanofi Sponsored ADR Stock Analysis

Unlock Scores for Free

??

30 Analysts have issued a Sanofi Sponsored ADR forecast:

21x Buy

70%

8x Hold

27%

More details on Analyst Estimates Including Price Targets

30 Analysts have issued a Sanofi Sponsored ADR forecast:

Buy

70%

Hold

27%

Sell

Analyst Estimates with Stock Price Targets

Financial data from Sanofi Sponsored ADR

Income Statement P&L | Balance Sheet | Cash Flow

Quarter TTM Annually

Mar '25		+/- %
Revenue	81,108 81,108	- 100%
- Direct Costs	23,703 23,703	- 29%
Gross Profit	57,405 57,405	- 71%
- Selling and Administrative Expenses	16,546 16,546	- 20%
- Research and Development Expense	12,985 12,985	- 16%
EBITDA	21,894 21,894	- 27%
- Depreciation and Amortization	3,086 3,086	- 4%
EBIT (Operating Income) EBIT	18,809 18,809	- 23%
Net Profit	12,037 12,037	- 15%

In millions USD.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Subscribe Now

Sanofi Sponsored ADR Stock News

Neutral

GlobeNewsWire

●

about 23 hours ago

Press Release: Sanofi's Sarclisa approved in the EU for the treatment of transplant-eligible newly diagnosed multiple myeloma

Sanofi's Sarclisa approved in the EU for the treatment of transplant-eligible newly diagnosed multiple myeloma

Negative

Reuters

●

3 days ago

Five years after COVID, pharma shares languish in US policy limbo

Global healthcare stocks have not been this cheap in decades and fund inflows into the sector are picking up, yet the shares remain in the doldrums, highlighting uncertainty over drug pricing policies since Donald Trump returned to the White House.

Positive

Reuters

●

4 days ago

France's Sanofi to acquire biotech firm Vicebio for $1.15 bln

French pharmaceuticals company Sanofi said on Tuesday it agreed to acquire British private biotechnology firm Vicebio for a total of $1.15 billion, in a bid to expand its respiratory vaccines portfolio.

More Sanofi Sponsored ADR News

Company Profile

Sanofi engages in the research, production, and distribution of pharmaceutical products. It operates through the following business segments: Pharmaceuticals, Consumer Healthcare, and Vaccines. The Pharmaceuticals segment comprises the commercial operations of the following global franchises: specialty care, diabetes and cardiovascular, established prescription products and generics, and research, development, and production activities. The Consumer Healthcare segment includes the commercial operations for its Consumer Healthcare products. The Vaccines segment consists commercial operations of Sanofi Pasteur. The company was founded in 1973 and is headquartered in Paris, France.

Head office	France
CEO	Paul Hudson
Employees	82,878
Founded	1994
Website	www.sanofi.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

Start now